As a proof of concept, inhibition of various metabolic targets, such as LDHA and glutaminase, reduced tumor growth, and extended survival in Myc-dependent and Myc-inducible cancer models, although the synthetic lethality with Myc was not specifically demonstrated (Hsieh and Dang, 2016). The gene discussed is MYC; the disease is neoplasm.